Alkermes plc. Restructuring Reserve
Alkermes plc. (ALKS) had Restructuring Reserve of $1.33 million as of 2023-12-31, per its 10-K filed 2024-02-21.
Discontinued › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2024-02-21
- 2023-12-31: Restructuring Reserve $1.33M.
- 2023-09-30: Restructuring Reserve $3.37M.
- 2020-12-31: Restructuring Reserve $462.00K.
- 2020-09-30: Restructuring Reserve $1.16M.
| Period end | Restructuring Reserve | Restructuring Reserve as first filed |
|---|---|---|
| 2023-12-31 | $1.33M 10-K · filed 2024-02-21 | |
| 2023-09-30 | $3.37M 10-Q · filed 2023-10-25 | |
| 2020-12-31 | $462.00K 10-K · filed 2021-02-11 | |
| 2020-09-30 | $1.16M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $2.23M 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $4.61M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $9.20M 10-K · filed 2021-02-11 | |
| 2015-03-31 | $1.44M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $2.00M 10-Q · filed 2015-04-30 | |
| 2014-09-30 | $4.27M 10-Q · filed 2014-10-29 | |
| 2014-06-30 | $8.16M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $8.54M 10-Q · filed 2014-04-30 | |
| 2013-12-31 | $7.30M 10-K · filed 2015-02-24 | |
| 2013-03-31 | $12.30M 10-Q · filed 2014-10-29 | $602.00K 10-KT · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |